Screener
Zymeworks ZYME Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Zymeworks’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001937653-26-000047
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total other comprehensive (loss) income | (129) | 66 | (615) | 612 |
| Comprehensive (loss) income | $(45,148) | $2,383 | $(89,796) | $(19,707) |
| Net (loss) income per common share: | ||||
| Basic | $(0.62) | $0.03 | $(1.21) | $(0.27) |
| Diluted | $(0.62) | $0.03 | $(1.21) | $(0.27) |
| Weighted-average common stock outstanding: | ||||
| Basic | 72,993,313 | 75,337,168 | 73,826,423 | 75,254,553 |
| Diluted | 72,993,313 | 77,378,449 | 73,826,423 | 75,302,357 |
Item 1. Financial Statements
FAQ
- What is Zymeworks's shares (diluted)?
- Zymeworks (ZYME) reported shares (diluted) of 73M in Q2 2026.
- How has Zymeworks's shares (diluted) changed year-over-year?
- Zymeworks's shares (diluted) decreased by 5.7% year-over-year, from 77.4M to 73M.
- What is the long-term trend for Zymeworks's shares (diluted)?
- Over 3 years (2022 to 2025), Zymeworks's shares (diluted) has grown at a 5.4% compound annual growth rate (CAGR), from 259.5M to 303.8M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Zymeworks's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude